课题基金 / 基金详情

Regulation of IGF-2 gene expression in human chondrosarcoma derived cell lines : HCS-2/8 and -2/A

Regulation of IGF-2 gene expression in human chondrosarcoma derived cell lines : HCS-2/8 and -2/A
人软骨肉瘤衍生细胞系中 IGF-2 基因表达的调节:HCS-2/8 和 -2/A
批准号:
08672124
负责人:
TAKAHASHI Kojiro
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

TAKAHASHI Kojiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In chondrocytes without vascula, autocrine function of insulin-like growth factor-2 (IGF-2) is very important for the growth and differentiation. Regulation on the expression of IGF-2 gene (IGF-2) in human chondrosarcoma derived cell lines (HCS-2/8 and -2/A) was investigated in order to explore the function of IGF-2.In human chondrocytes, all four promoters of IGF-2 are expressed, and consensus binding sequenses to the transcriptional factors ; EGR1 (early growth response gene product 1), SP-1 (specificity protein-1) and WT1 (Wilms tumor suppresor), are localizing over the transcriptional regulation region of IGF-2 promoters. Although the expression of SP-1 is very slight in both of normal chondrocytes and HCS-2/8, EGR1 expression in HCS-2/8 was higher than that in normal chondrocytes and WT1 expression in HCS-2/8 was lower thatn that in normal chondrocytes. This suggests that the abnormal growth of chondrosarcoma-derived HCS-2/8 may be induced with the synergistic effect between a positive function of EGR1 and negative one of WT1 to the growth enhancement during the initial growth phase.The effects of ascorbic acid in HCS-2/8 were positive to the gene expression of IGF-2, H19 (tumore suppresor), EGR1, SP-1, WT1, type-10 collagen alpha1, aggrecan and alkaline phosphatase, but negative to that of type-2 collagen alpha1. These results suggest that the role of ascorbic acid in chondrocytes may be as a growth and differetiational factor during the phases to differentiation from growth.The imprinting status of IGF-2 in HCS-2/8 was paternal alleles for all the promoters, and seem to be independent directly on the excess gene expression. On CDKNIC (p57^<KIP2>) in the imprinting cluster over human chromosome 11p15.5 region, a lacking of PA in the PAPA-repeat was detected for the paternal allele in HCS-2/8, and the expressed allele was maternal.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Takigawa, Masaharu: "The Basic Effect of IGF on Chondrocytes" Clin.Pediatr.Endocrinol.6 (Suppl 10)(in printing). (1997)
Takikawa, Masaharu:“IGF 对软骨细胞的基本影响”Clin.Pediatr.Endocrinol.6(增刊 10)(印刷中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takigawa, Masaharu et al.: "Insulin-Like Growth Factors I and II Are Autocrine Factors in Stimulating Proteogglycan Synthesis, a Marker of Differentiated Chondrocytes, Acting through Their Respective Receptors on a Clonal Human Chondrosarcoma-Derived Chon
Takikawa, Masaharu 等人:“胰岛素样生长因子 I 和 II 是刺激蛋白聚糖合成的自分泌因子,蛋白聚糖是分化软骨细胞的标志物,通过各自的受体作用于克隆性人软骨肉瘤衍生的软骨上
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takigawa, Masaharu: "Insulin-Like Growth Factors I and II Are Autocrine Factors in Stimulating Proteoglycan Synthesis, a Marker of Differentiated Chondrocytes, Actingthrough Their Respective..." Endocrinology. 138 (10). 4390-4400 (1997)
Takikawa, Masaharu:“胰岛素样生长因子 I 和 II 是刺激蛋白多糖合成的自分泌因子,蛋白多糖是分化软骨细胞的标志物,通过它们各自发挥作用......”内分泌学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Search for agonists of new plasma membrane estrogen receptors and their anti-stress effects
Effects of chemical compounds derived from plants on the functions of catecholaminergic neurons and life span
Effects of environmental estrogenic pollutants on cellular functions in the noradrenergic neurons and search for their receptors
Expression and promoter-alternation of osteoblastic insulin-like growth factors
  • 批准号:
    06671854
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.41万
  • 财政年份:
    1994
  • 负责人:
    TAKAHASHI Kojiro
  • 依托单位:
国内基金
海外基金
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
  • 批准号:
    82371603
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈晓
  • 依托单位: